![Thomas Schenk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Thomas Schenk served as the Chief Medical Officer at ImpediMed Ltd. from 2022 to 2023.
Prior to this, he obtained undergraduate degrees from Cornell University and Jacobs School of Medicine & Biomedical Sciences.
Eerdere bekende functies van Thomas Schenk
| Bedrijven | Functie | Einde |
|---|---|---|
| IMPEDIMED LIMITED | Hoofd Techniek/Wetenschap/O&O | 26-09-2023 |
Opleiding van Thomas Schenk
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
9
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImpediMed Ltd.
 ImpediMed Ltd. Medical SpecialtiesHealth Technology Develops and distributes medical devices for use clinical assessment and monitoring of human disorders and diseases | Health Technology |
Jacobs School of Medicine & Biomedical Sciences
 Jacobs School of Medicine & Biomedical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
